Clinical Trials Logo
  1. Home
  2. Partial Seizures
  3. NCT04257604

A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures

Partial Seizures Clinical Trial

Official title:
A Multicenter, Prospective, Real-life Observational Study of Perampanel as Add-on Therapy in Adult and Adolescent Patients With Focal Seizures (A Mirroring Clinical Practice Study of Perampanel in Adults and Adolescents) (The AMPA Study)

Clinical Trial Summary

The primary objective of the present study will be to assess the effectiveness of add-on perampanel in participants with focal seizures in a real-life clinical setting.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04257604
Study type Observational
Source Eisai Inc.
Contact
Status Completed
Phase
Start date January 3, 2016
Completion date April 30, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT01954121 - Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures Phase 3
Completed NCT01630057 - Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug Phase 4
Completed NCT00327717 - Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures Phase 3
Completed NCT00537238 - Pregabalin Versus Levetiracetam In Partial Seizures Phase 3
Completed NCT00141258 - Pregabalin Epilepsy Add-On Trial Phase 3
Completed NCT03340064 - A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age Phase 3
Terminated NCT00407797 - Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial Phase 4
Completed NCT01136954 - A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study) Phase 3
Completed NCT01392768 - Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization Phase 3
Completed NCT01063764 - An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures Phase 3
Completed NCT00102713 - A Study for Treatment of Partial Seizures in Children Phase 3
Completed NCT01262677 - Once-A-Day Pregabalin For Partial Seizures Phase 3